Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn’s Disease: The OPERA II Study

Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease

(2018) A. Barré et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned

(2018) Eugene O Major et al.   LANCET NEUROLOGY

Can We Predict the Efficacy of Anti-TNF-α Agents?

(2017) Loris Lopetuso et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn’s Disease: Report of the TOSCA Study

(2017) Geert D’Haens et al.   Journal of Crohns & Colitis

Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial

(2017) Séverine Vermeire et al.   LANCET

A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy

(2014) Salim Chahin et al.   JOURNAL OF NEUROVIROLOGY

JC Virus in CD34+and CD19+Cells in Patients With Multiple Sclerosis Treated With Natalizumab

(2014) Elliot M. Frohman et al.   JAMA Neurology

Crohn's disease

(2012) Daniel C Baumgart et al.   LANCET

The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study

(2011) S. Vermeire et al.   GUT

Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity

(2010) Severine Vermeire et al.   Clinical Gastroenterology and Hepatology

Review: Anti-adhesion molecule therapy for inflammatory bowel disease

(2010) Subrata Ghosh et al.   Therapeutic Advances in Gastroenterology

CNS Elevation of Vascular and Not Mucosal Addressin Cell Adhesion Molecules in Patients with Multiple Sclerosis

(2009) Rachel Allavena et al.   AMERICAN JOURNAL OF PATHOLOGY

Pharmacological characterization of PF-00547659, an anti-human MAdCAM monoclonal antibody

(2009) N Pullen et al.   BRITISH JOURNAL OF PHARMACOLOGY

W1042 Mechanistic Population Pharmacokinetics (PK) Model of PF-00547659, a Fully Human IgG2 Anti-MAdCAM Antibody, in Ulcerative Colitis Patients: Results of a First in Human (Fih) Study

(2009) Steven W. Martin et al.   GASTROENTEROLOGY

The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans

(2008) F. Zohren et al.   BLOOD

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

(2008) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology